{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:35:28Z","timestamp":1759336528881,"version":"3.41.2"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pharep.2016.12.001","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T01:31:44Z","timestamp":1480901504000},"page":"350-357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Methyl-orvinol\u2014Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome"],"prefix":"10.1007","volume":"69","author":[{"given":"Marta","family":"Zieli\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Jarmu\u017c","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrzej","family":"Wasilewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerta","family":"Cami-Kobeci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Husbands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1\u20133","key":"10.1016\/j.pharep.2016.12.001_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2009.03.012","article-title":"Opioid receptors in the gastrointestinal tract","volume":"155","author":"Holzer","year":"2009","journal-title":"Regul Pept"},{"issue":"1","key":"10.1016\/j.pharep.2016.12.001_bib0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00535-013-0753-x","article-title":"Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives","volume":"49","author":"Sobczak","year":"2014","journal-title":"J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.001_bib0015","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jphp.12335","article-title":"Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome","volume":"67","author":"Zielinska","year":"2015","journal-title":"J Pharm Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2016.12.001_bib0020","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.pharep.2016.12.001_bib0025","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1021\/ja00989a032","article-title":"Novel analgesics and molecular rearrangements in the morphine-thebaine group 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and \u2212norcodeine","volume":"89","author":"Bentley","year":"1967","journal-title":"J Am Chem Soc"},{"issue":"8","key":"10.1016\/j.pharep.2016.12.001_bib0030","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1021\/jm301543e","article-title":"Orvinols with mixed kappa\/mu opioid receptor agonist activity","volume":"56","author":"Greedy","year":"2013","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.pharep.2016.12.001_bib0035","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/1381612043453027","article-title":"The orvinols and related opioids-high affinity ligands with diverse efficacy profiles","volume":"10","author":"Lewis","year":"2004","journal-title":"Curr Pharm Des"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.001_bib0040","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jphp.12335","article-title":"Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome","volume":"67","author":"Zielinska","year":"2015","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"10.1016\/j.pharep.2016.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2982.2009.01369.x","article-title":"Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors","volume":"21","author":"Fichna","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.pharep.2016.12.001_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.peptides.2014.08.005","article-title":"Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases","volume":"60","author":"Sobczak","year":"2014","journal-title":"Peptides"},{"issue":"5","key":"10.1016\/j.pharep.2016.12.001_bib0055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjp.0706368","article-title":"The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors","volume":"146","author":"Hyland","year":"2005","journal-title":"Br J Pharmacol"},{"issue":"11","key":"10.1016\/j.pharep.2016.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3748\/wjg.v10.i11.1672","article-title":"Effects of mu and kappa opioid receptor agonists and antagonists on contraction of isolated colon strips of rats with cathartic colon","volume":"10","author":"Liu","year":"2004","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.001_bib0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jphp.12335","article-title":"Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome","volume":"67","author":"Zielinska","year":"2015","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2016.12.001_bib0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharep.2015.06.001","article-title":"Mixed MOP\/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms","volume":"68","author":"Zielinska","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"5","key":"10.1016\/j.pharep.2016.12.001_bib0075","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1476-5381.2012.02068.x","article-title":"Modulation of gastrointestinal function by MuDelta, a mixed micro opioid receptor agonist\/micro opioid receptor antagonist","volume":"167","author":"Wade","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"10.1016\/j.pharep.2016.12.001_bib0080","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(96)00668-1","article-title":"Gastrointestinal actions of buprenorphine: are different receptors involved?","volume":"316","author":"Bhounsule","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2016.12.001_bib0085","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.3748\/wjg.v19.i9.1444","article-title":"Effect of thienorphine on intestinal transit and isolated guinea-pig ileum contraction","volume":"19","author":"Zhou","year":"2013","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.001_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0163-7258(95)02053-5","article-title":"Insights into opioid action in the intestinal tract","volume":"69","author":"De","year":"1996","journal-title":"Pharmacol Ther"},{"issue":"4 Pt 1","key":"10.1016\/j.pharep.2016.12.001_bib0095","first-page":"G633","article-title":"Regulation of intestinal Cl- and HCO3-secretion by uroguanylin","volume":"274","author":"Joo","year":"1998","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.pharep.2016.12.001_bib0100","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1476-5381.1994.tb17113.x","article-title":"Dissociation of castor oil-induced diarrhoea and intestinal mucosal injury in rat: effect of NG-nitro-L-arginine methyl ester","volume":"113","author":"Capasso","year":"1994","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.pharep.2016.12.001_bib0105","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.3109\/13880209.2012.656850","article-title":"Antinociceptive antidiarrheal, and neuropharmacological activities of Barringtonia acutangula","volume":"50","author":"Zafar","year":"2012","journal-title":"Pharm Biol"},{"issue":"1","key":"10.1016\/j.pharep.2016.12.001_bib0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0022-3565(24)38161-3","article-title":"Loperamide (ADL 2\u20131294), an opioid antihyperalgesic agent with peripheral selectivity","volume":"289","author":"DeHaven-Hudkins","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.pharep.2016.12.001_bib0115","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/003655201300191996","article-title":"Antisecretory effect of loperamide in colon epithelial cells by inhibition of basolateral K+ conductance","volume":"36","author":"Epple","year":"2001","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.pharep.2016.12.001_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0975-9476.146542","article-title":"Antidiarrheal activity of ethanolic extract of Manihot esculenta Crantz leaves in Wistar rats","volume":"6","author":"Bahekar","year":"2015","journal-title":"J Ayurveda Integr Med"},{"issue":"7","key":"10.1016\/j.pharep.2016.12.001_bib0125","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1016\/j.bmc.2014.02.015","article-title":"Endomorphin analogues with mixed mu-opioid (MOP) receptor agonism\/delta-opioid (DOP) receptor antagonism and lacking beta-arrestin2 recruitment activity","volume":"22","author":"Cai","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.pharep.2016.12.001_bib0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00210-011-0652-8","article-title":"TH-030418: a potent long-acting opioid analgesic with low dependence liability","volume":"384","author":"Yu","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016304121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:48Z","timestamp":1752611808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.12.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1734114016304121"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.001","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methyl-orvinol\u2014Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}